Dr Shinji Ohno

Go Back

Medical Oncologist

  • Cancer Institute Hospital of JFCR
  • location Japan
Dr Shinji Ohno has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Chugai, Eisai, Eli Lilly, KyowaHakko, Kirin and Taiho

Programmes developed by Dr Shinji Ohno

Oncology 
An Experts’ Forum in Tokyo and Singapore on DDR and PARP inhibition

Experts
Prof. Keiichi Fujiwara, Prof. Simon Boulton, Dr Shinji Ohno, Dr Rebecca Dent, Prof. Charlie Gourley
  • download Downloadable
    Resources
  • clock 60 MIN
  • calendar Sep 2021

This educational programme is supported by an Independent Educational Grant from AstraZeneca